STOCKS TELEGRAPH

Author: Mahrukh Rehan

  • Mersana Therapeutics, Inc. (MRSN) stock is on a boost – What’s driving it higher?

    Mersana Therapeutics, Inc. (MRSN) stock is on a boost – What’s driving it higher?

    Mersana Therapeutics, Inc. (MRSN) experienced an increase of 8.55% in aftermarket following the update in SEC filing. However, the last trading session closed at $4.33 with a decrease of 3.78%.

    Research Collaboration and License Agreement by MRSN– What’s this?

    On 3rd February 2022, MRSN announced that Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson, has agreed to collaborate on research and develop novel ADCs for three targets with the company.

    Moreover, the totally homogeneous Dolasynthen platform offers both precision control and the capacity to alter the drug-to-antibody ratio (DAR) throughout a wide range. Furthermore, Dolasynthen offers a one-of-a-kind possibility to create the best ADC for a certain target. Lastly, the company is excited to bring the Dolasynthen platform’s unique features as well as extensive experience with ADC optimization to this partnership.

    2022 Strategic Priorities and Milestones by MRSN – More About it

    MRSN reported the company’s strategic priorities and milestones for 2022 on 7th January 2022. By 2021, the company will have made good advances in implementing the four strategic pillars that underpin the view of transforming Mersana into an ADC leader. The strategic implementations include:

    • transforming UpRi into fundamental healthcare in ovarian cancer,
    • progressing a diversified pipeline of first-in-class ADCs attempting to address areas of high unmet clinical need,
    • driving ADC advancement,
    • and transforming Mersana into an organization with global talent.

    MRSN has built a highly diversified project proposal with the goal of offering UpRi to a large group of ovarian cancer individuals with chronic alternatives, with UPLIFT and UPGRADE ongoing and UP-NEXT set to begin in Q2 2022. Lastly, the company is developing and strengthening the pipeline by using the three revolutionary product engines.

    2021 List of Top Places to Work in Massachusetts

    On 2nd December 2021, MRSN reported that the company has been indexed in the 2021 List of Top Places to Work in Massachusetts. The company is thrilled to earn this accolade, which reflects the strong culture and dedicated staff members who display their commitment to the purpose and core values on a daily basis. Furthermore, the company creates outcomes with agility, creativity, and passion at Mersana. Despite the enormous hurdles that the COVID-19 epidemic posed to the employees and their families, the team has thrived thanks to the common goal of providing new therapeutic choices to cancer patients.

  • Liberty Oilfield Services Inc. (LBRT) stock is experiencing a downfall – Learn more about it!

    Liberty Oilfield Services Inc. (LBRT) has experienced a decrease of 6.54% in aftermarket following the announcement of the fourth quarter and full-year 2021 results. However, the last trading session closed at $11.77 with a decrease of 4.46%.

    Fourth Quarter & Full Year Results in 2021 by LBRT – What’s going on?

    LBRT announced fourth-quarter and full-year 2021 results on 8th February 2022. The company recorded net revenue of $2.5 billion and a net loss of about $187 million. Moreover, the adjusted EBITDA came out to be $121 million. The company says that business integrations are typically difficult, but they’re even more difficult this time due to the Covid-affected supply chain and workforce shortages.

    The prize, however, was substantial, and the team worked tirelessly to hire approximately 2,000 new employees while continuing to provide exceptional service to all of the clients, both old and new. Lastly, consolidation and transition efforts impacted adjusted EBITDA by more than $20 million in the fourth quarter, according to the estimates.

    Now what?

    During the year 2021, LBRT broke a number of operational records. Moreover, the merger of OneStim and its clients into Liberty was the main focus in 2021. During a downturn, the company bought OneStim to bolster the platform and technology portfolio, positioning the team for today’s rising tide and all future cycles. Furthermore, the company has experienced two deep downturns in its eleven-year history: 2015 to 2016 and the most recent Covid-induced downturn, still LBRT has completed transformative transactions in both. At Liberty, the team always makes investment decisions with a long-term view in mind.

    Third Quarter 2021 Results by LBRT – How was the quarter?

    LBRT reported third-quarter 2021 results on 27th October 2021. According to the report, the company experienced revenue of $654 million with a 12% sequential increase. Moreover, the adjusted EBITDA came out to be $32 million. Not only this but the company announced the merger with Proppant Express Investments.

    So what?

    Strong manufacturing fundamentals and the need for Liberty drove increased activity and progress in the fourth quarter and into 2022. In light of this, Liberty announced the signing of the first two multi-year agreements with long-standing Liberty clients for the deployment of Liberty’s digiFrac electric fleets in 2022. The first purpose-built electric frac fleet’s technological inventiveness and design have been highly accepted by E&P operators, and LBRT is working with them to establish a multi-year deployment strategy.

  • Chipotle Mexican Grill, Inc. (CMG) stock is moving up – Here’s why?

    Chipotle Mexican Grill, Inc. (CMG) experienced an increase of 6.62% in aftermarket following the announcement of the fourth quarter and full-year 2021 results. However, the last trading session closed at $1460.35 with an increase of 0.51%.

    Fourth Quarter 2021 Results – What’s new?

    CMG announced fourth-quarter 2021 results on 8th February 2022. The company reported that the revenues jumped 22% and reached almost $2.0 billion. Not only this but the comparable restaurant sales inclined to 15.2% with digital sales experiencing around 3.8% increase. Furthermore, the restaurant-level operating margin came around 20.2% giving an increase of 70 basis points. Last but not the least, the company also launched 78 new restaurants at amazing locations.

    CMG: The full Year 2021 Results – More About it

    CMG stated full-year 2021 results on 8th February 2022. According to the results, the company has seen to experience a total revenue of about $7.5 billion with an incline of 26.1%. Moreover, digital sales increased by 24.7% and reached 45.6% of sales. Not only this but the operating margin rose to 10.7% and diluted earnings per share came out to be $22.90. Last but not the least, the company successfully opened 215 restaurants in the entire year.

    How was the year for CMG?

    Chipotle had an exceptional year in 2021, demonstrating the brand’s power and endurance. As the dedicated workers remained committed to providing outstanding guest experiences in line with the mission and values, the company did many incredible things together. Moreover, expanding access and convenience through the digital ecosystem, driving unit development, and continuing to train and support the restaurant staff will place the company in a much stronger competitive position going forward.

    Launch of Plant-Based Chorizo & New Lifestyle Bowls – Worth it?

    On 3rd January 2022, CMG reported that Plant-Based Chorizo is now available in certain locations across the United States for a limited period. Plant-Based Chorizo is a new, crave-able protein prepared with all-natural, quality ingredients cultivated on a farm rather than in a laboratory. The Chipotle app, Chipotle.com, and third-party delivery partners are now offering the brand’s latest menu innovation.

    The company is ecstatic to present the new, flavor-packed Plant-Based Chorizo to guests during a time of year. Lastly, the company believes that Plant-Based Chorizo is their most flavorful chorizo yet, proving that a vegan or vegetarian protein doesn’t have to be tasteless.

  • Enphase Energy, Inc. (ENPH) stock is jumping high to 16.47% – What’s behind it?

    Enphase Energy, Inc. (ENPH) saw a push of 16.47% in the aftermarket because the company reported fourth-quarter 2021 results. However, the last trading session closed at $144.50 with an increase of 2.65%.

    Fourth Quarter 2021 Results – Latest Stats by ENPH

    ENPH announced fourth-quarter 2021 results on 8th February 2022. The company recorded revenue of about $412.7 million. Not only this but GAAP gross margin came out to be 39.6% and GAAP operating income totaled $57.7 million. Furthermore, cash flow from operations was $97.2 million. Last but not the least, GAAP operating income came out to be $52.6 million whereas non-GAAP net income recorded was $102.8 million.

    Now what?

    In the fourth quarter of 2021, the company completed the acquisition of ClipperCreek. It provides residential and commercial customers in the United States with electric vehicle (EV) charging options. Moreover, the growing popularity of electric vehicles has consequences for residential energy management. With an EV, homes will require substantially more energy, and the enormous EV battery may one day be used for backup and grid services. Lastly, the power conversion and software platform will soon be used to manage loads and resources within the home.

    Expansion of Battery Storage in Arizona by ENPH – What’s up?

    On 3rd February 2022, ENPH reported about the expansion of battery storage in Arizona. IQ Microinverters and IQ Batteries will power the entire expansion process. According to the most current U.S. Census Bureau report, Arizona’s household storage capacity is continuously increasing year over year, with forecasts indicating deployments will more than quadruple in the next year and more than 8-fold by 2026. Moreover, Enphase offers a solar-plus-battery system that protects installers and homeowners from high-voltage DC exposure. The battery chemistry used in the Enphase IQ Battery is Lithium Iron Phosphate (LFP), which has a long cycle life and great thermal stability, making it safer to use.

    What’s Next?

    Arizona is beginning to recognize the evident value of home solar and batteries for both individual households and the overall grid. In addition, by partnering with Enphase, the company is able to help the consumers take charge of their home energy future by providing some of the most dependable and advanced technologies available.

    Furthermore, the companies happily partner with Enphase to offer their customers the greatest quality products and customer experience available. Lastly, Enphase’s micro inverter-based solar and battery solutions provide greater energy management, dependability, and a more simplified process in general.

  • Alterity Therapeutics Limited (ATHE) stock is going up – What’s driving it higher?

    Alterity Therapeutics Limited (ATHE) has seen a push of 7.11% in premarket despite any latest news released by the company. However, the last trading session closed at $0.98 with an increase of 7.84%.

    ATH434 Being Neuroprotective – Latest News by ATHE

    On 28th January 2022, ATHE announced that the Journal of Parkinson’s Disease recently published evidence from an animal model of Multiple System Atrophy (MSA). MSA is a debilitating neurological disease for which there is no recognized treatment.

    The preclinical findings are extremely important because they support the hypothesis. The hypothesis stated that by binding and redistributing excess iron in the brains of Parkinson’s disease patients, they can decrease synuclein aggregation and oxidative stress, as well as rescue neurotransmitters in multiple brain regions. This addresses the disease’s underlying pathology. Last but not the least, ATHE anticipates that these preclinical studies will lead to clinical benefit in MSA patients.

    New US Patent – What’s up?

    On 6th January 2022, ATHE reported that the company has been granted a new patent number by the USPTO. The USPTO prioritized the investigation of the composition of matter patent, “Compounds for and Methods of Treating Diseases.” The patent includes more than 80 new compounds and grants exclusivity to a new class of iron chaperones meant to disperse excess iron.

    ATHE is still looking for new medication candidates to contribute to the portfolio and safeguard the neurodegenerative therapeutic approach. Moreover, ATHE is developing a strong basis as a leader in targeting iron for a possible disease-modifying therapy for critical neurological illnesses including Parkinson’s and Alzheimer’s.

    First Regulatory Authorization by ATHE – What’s going on?

    On 14th December 2021, ATHE announced that Alterity’s Phase 2 clinical trial for ATH434 in Multiple System Atrophy (MSA), a rare and very debilitating Parkinsonian illness, has been approved by the New Zealand Medicines and Medical Devices Safety Authority. The approval of the New Zealand health authorities to proceed with the Phase 2 clinical research is an important milestone. This happens because it opens the door for the study to begin in the first quarter of next year. By preventing -synuclein aggregation and restoring iron balance in the brain, ATH434 uses a novel strategy to treat the underlying pathophysiology of MSA.

  • RISE Education Cayman Ltd (REDU) stock is moving high in premarket – Find out the actual reason.

    RISE Education Cayman Ltd (REDU) stock has seen an increase of 9.45% in premarket despite any official news. However, the last trading session closed at $0.51 with a decrease of 0.59%.

    Nasdaq Notice – What’s up?

    REDU announced on 18th January 2022 that the company has received Nasdaq notice of Non-compliance and Non-binding Proposals for a Business Combination. The Nasdaq Stock Market LLC informed the Company that its Listing Qualifications department had decided that the Company’s securities would be delisted unless the Firm filed a review before a Nasdaq Hearings Panel in a timely manner.

    Closure of Sale of Rising – More About it

    On 30th December 2021, REDU announced the closure of the Sale of Rising. The company has sold all the equity interests to Wuhan Xinsili Culture Development Co., Ltd and Bain Capital Rise Education IV Cayman Limited. Not only this but the settlement with lenders ended in connection with the Sale on December 30, 2021. As part of the Settlement, the Lenders have ceded all interests in the Edge business, which provides admission counseling, academic tutoring, and test prep solutions to students planning to study abroad in Hong Kong and Singapore.

    About REDU

    RISE presents a highly dynamic American K-12 curriculum based on tight requirements while delivering interactive multimedia to kids both in and out of the classroom, based on HMHG’s professional experience and great goods. Moreover, REDU has become a progressive household name in the English language learning sector after ten years of growth.

    Not only this but REDU provides youngsters with the opportunity to learn English in a fun and fully immersive setting that will pique their interest in the subject. RISE not only improves children’s language skills, but also teaches them how to comprehend the logic, cultural nuances, and reasoning procedures that underpin language. Lastly, RISE also emphasizes the development of leadership abilities in children, such as teamwork, presentation, project management, problem-solving, and creativity.

  • Kforce Inc. (KFRC) stock is down to 7.48% in aftermarket – What’s going on?

    Kforce Inc. (KFRC) stock is down to 7.48% in aftermarket – What’s going on?

     Kforce Inc. (KFRC) experienced a decrease of 7.48% in the aftermarket because the company announced the fourth quarter and full-year 2021 results. However, the last trading session closed at $68.09 with a decrease of 0.10%.

    Fourth Quarter and Full Year 2021 Results by KFRC – What’s up?

    KFRC announced fourth-quarter and full-year 2021 results on 7th February 2022. The company experienced revenue of about $410.4 million. Not only this, but technology revenue showed an increase of almost 32%. The FA revenue fall down to 25.5% with a gross profit margin increased to almost 80 points. Furthermore, the general and administrative expenses came out to be 22.9% increasing 170 basis points. Last but not the least, the net income was $20.6 million.

    Now what?

    The company is quite happy with the success in 2021 and feels that the competitive strategy and momentum into 2022 have properly positioned KFRC to keep producing substantially above-market sales growth. The company has streamlined Kforce’s strategic emphasis to provide domestic technological talent solutions to innovative and industry-leading organizations, accounting for 85 percent of the revenue.

    Moreover, this strategic move was daring and disruptive, but it was based on the conviction that technology will be at the heart of nearly every company strategy. Not only this but KFRC feels that they have the right people in place to expand the market share and the company expects that this will continue to be an extremely high-demand environment for the services.

    Updates regarding Joseph J. Liberatore and David L. Dunkel

    KFRC announced on 6th December 2021 that the company has appointed David L. Dunkel as the CEO of the company whereas Joseph J. Liberatore will be added to the Board of Directors. The entire Board is ecstatic, and this announcement is the conclusion of a meticulously crafted succession planning process. Moreover, David has proved his vision for Kforce and his unrelenting dedication to achieving extraordinary results throughout the course of his more than 40 years as CEO.

    On the other hand, Joe’s vision and leadership qualities have been on display for many years, and he guided the firm through the global pandemic while keeping a steady eye on the future. Lastly, Joe will continue to build on his history as he leads Kforce into the future, delivering excellent outcomes for the shareholders.

  • loanDepot, Inc. (LDI) stock is on a boost in aftermarket – Recent News

    loanDepot, Inc. (LDI) experienced an increase of 5.32% in aftermarket following the update in SEC filing. However, the last trading session closed at $3.57 with a decrease of 5.31%.

    Fourth Quarter 2021 results – Revealed by LDI

    LDI announced fourth-quarter 2021 results on 1st February 2022. The company experienced a net income of $14.7 million which was less than that of $154.3 million in the prior quarter. Moreover, the adjusted EBITDA decreased to $63.7 million and total expenses came out to be $50.6 million.

    Furthermore, the company is working hard to ensure that its operations reflect these shifting market realities effectively. The team is working to make significant investments in technology to improve operational efficiencies, expand the in-market retail mortgage origination capabilities, and improve the in-house servicing platform. Even if total origination volume diminishes, the company will have all of the tools to take market share.

    So what?

    The plan worked in 2021, as the company increased its market share during a period of shifting market conditions. Moreover, the market dynamics have been encountered before by LDI’s seasoned leadership team, which has collectively weathered multiple housing and interest rate cycles over the last 35 years. Furthermore, the company was designed specifically for times of stress.

    The company manages the lead flow, customer interaction strategy, and point of loan origination. This has only been possible because of the proprietary software stack, purposely diversified mix of channels, and sophisticated performance marketing machine. Lastly, this is a crucial competitive advantage since it allows the team to pivot and alter the production in response to market conditions.

    Closing of $597 million securitization – Latest News

    LDI reported on 31st January 2022 that the company has announced the closing of $597 million securitizations of agency-eligible residential investment property mortgages. The strength of the multi-channel strategy, nationally renowned brand, and proprietary Mello tech stack highlights the unique and robust business model.

    Because of the regularity and scale of the program, LDI can provide bespoke capital transactions with better secondary market pricing for the loans. As the company continues to help the customers to manage their most critical financial transactions, the smart capital raising strategy and diversified financing approach continue to allow LDI operating flexibility.

  • Editas Medicine, Inc. (EDIT) stock is going down – What’s going on?

    Editas Medicine, Inc. (EDIT) saw a decrease of 7.04% in aftermarket following the update in SEC filing. However, the last trading session concluded at $19.32 with an increase of 3.15%.

    Recent Progress Announced – How is it?

    EDIT announced updates regarding the recent progress of the company on 10th January 2022. In its BRILLIANCE research of EDIT-101, Editas Medicine has finished dosing of all adult cohorts. Moreover, preliminary EDIT-101 trial data showed a positive safety profile and promising clinical benefit signs, which were previously announced. Following a safety assessment by an independent data monitoring committee, the Company plans to begin treating the pediatric high-dose group this year.

    Furthermore, in the second half of 2022, the company plans to release a clinical update on the BRILLIANCE trial, which will include safety and efficacy assessments on all patients. By the end of the year 2022, the company expects to have established registration trial criteria for EDIT-101.

    Editas Medicine, Inc. (EDIT): What’s Next?

    EDIT is creating a high-value pipeline of gene editing treatment candidates, powered by best-in-class next-generation technologies, including the efficient, high-precision, and SLEEK editing platform. With EDIT-101 in LCA10, the company achieved proof-of-concept in 2021, demonstrating the utility of the foundational in vivo approach in multiple ocular diseases.

    In addition, EDIT hopes to receive preliminary clinical data from the ex vivo EDIT-301 program in sickle cell disease this year. Lastly, the company is also looking forward to moving the alpha-beta T cell oncology program.

    Appointment of Dr. Jessica Hopfield – More About it

    EDIT reported about the appointment of Dr. Jessica Hopfield on 20th December 2021. The company is happy to welcome Dr. Hopfield to the Board. Moreover, Dr. Hopfield helps to bring to Berkeley Lights crucial strategic understanding and a clear emphasis on achievement to push the unrivaled ability to comprehend cell biology. Not only this but Dr. Jessica has more than two decades of medical device, biotech, and pharmacological experience. Lastly, the team is certain that her enthusiasm for collaborating with businesses to bring new ideas to market will make her an invaluable asset.

  • Society Pass Incorporated (SOPA) stock has jumped to 30.49% – Here’s why?

    Society Pass Incorporated (SOPA) has experienced an increase of 30.49% in aftermarket. However, the last trading session closed at $3.28 with a decrease of 16.11%.

    Addition to the Russell 2000 Index – Worth it?

    On 19th December 2021, SOPA announced that the firm has been added to the Russell 2000 Index successfully. The Russell 2000 Index examines the performance of small-cap stocks in the US stock market. The Russell 2000 Index is calculated on participation in the wide market Russell 3000 Index, and it will remain in existence until the next reconfiguration. Moreover, Russell indexes are frequently utilized as index funds and as benchmarks for active trading strategies. Last but not the least, Russell’s US indices are used to gauge assets worth around $10.6 trillion. Russell indexes are produced by FTSE Russell, one of the world’s premier index providers.

    Society Pass Incorporated (SOPA): What’s Next?

    This is a remarkable milestone for Society Pass to achieve so quickly following the successful initial public offering (IPO) in November. As SOPA endeavors to fulfill the goals for growth being a part of these highly recognized indices would bring greater market recognition to the Company.

    Launch of LeFlair Lifestyle E-Commerce Platform

    SOPA announced the launch of the LeFlair Lifestyle E-Commerce Platform on 13th December 2021. The recent debut of LeFlair into the Vietnam marketplace in early September has gone incredibly successfully. This can be seen by the revenues from the Leflair business unit in just the final three weeks of September.

    Moreover, the company believes that Society Pass is well-positioned to execute its strategic ambitions. This is supported by the conclusion of the IPO in early November, which produced gross proceeds of $28.125 million. Furthermore, these include boosting the platform marketing expenditure, launching the Society Points reward program, investing in more infrastructure like data centers, call centers, and warehouses, and funding e-commerce acquisitions in Southeast Asia (SEA) and South Asia.